ipn10200
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0
Earliest trial started Apr 6, 2021 (NCT04821089)
Timeline
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06937931 | Phase 2 | Jun 30, 2025 | Ipsen |
| NCT06625060 | Phase 2 | Oct 10, 2024 | Ipsen |
| NCT04752774 | Phase 1/Phase 2 (Phase 2) | Apr 29, 2021 | Ipsen |
| NCT04821089 | Phase 1/Phase 2 (Phase 2) | Apr 6, 2021 | Ipsen |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Ipsen | For profit | 4 | 4 | 1 | 2021 |
1 organizations
Page 1 / 1